Identifying new therapeutics for endometriosis using high throughput molecular and compound phenotypic screens

Project Details

An increasingly popular approach to in vitro drug discovery is high-throughput screening (HTS). In addition to the therapeutic applications of drug discovery, HTS screens can also expand our knowledge about the molecular characteristics of cell function.

We are using HTS technology to identify drugs that could be suitable to investigate for therapeutic use in endometriosis, and which further our knowledge and understanding of the cellular pathways involved in endometriosis.

Researchers

Prof Peter Rogers –Research Director at the Women’s

Dr Sarah Holdsworth-Carson - Research Fellow

Dr Jacqueline Donoghue - Research Fellow

Dr Megan Cock – Project Officer

Leonie Cann – Research Assistant

Molly Churchill – Research Assistant

Funding

This research has been funded by the Medical Research Future Fund (MRFF).

Research Opportunities

This research project is available to PhD students, Masters by Research, Honours students, Master of Biomedical Science to join as part of their thesis.
Please contact the Research Group Leader to discuss your options.

Research Group

Gynaecology Research Centre - Rogers Group


School Research Themes

Women's Health



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Obstetrics and Gynaecology

Node

Royal Women’s Hospital

MDHS Research library
Explore by researcher, school, project or topic.